Noboru Yamamichi
Overview
Explore the profile of Noboru Yamamichi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
176
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito T, Oura S, Nagamine S, Takahashi M, Yamamoto N, Yamamichi N, et al.
Clin Breast Cancer
. 2017 Oct;
18(4):e495-e500.
PMID: 29079443
Purpose: To validate the safety and efficacy of percutaneous radiofrequency ablation (RFA) of breast carcinomas. Methods: This retrospective study was conducted by the Breast Cancer Society for Minimally Invasive Therapy...
2.
Hamaguchi T, Shirao K, Yamamichi N, Hyodo I, Koizumi W, Seki S, et al.
Jpn J Clin Oncol
. 2008 Jun;
38(6):432-7.
PMID: 18515821
Objective: As prognosis of advanced gastric cancer is still poor, a standard regimen after first-line fluorouracil (FU)-based chemotherapy has not yet been established. Therefore, we conducted a phase II study...
3.
Ohtsu A, Boku N, Yoshioka T, Hyodo I, Shirao K, Shimada Y, et al.
Jpn J Clin Oncol
. 2003 Feb;
33(1):28-32.
PMID: 12604721
Purpose: To evaluate the antitumor effect and feasibility of a combination of irinotecan (CPT-11) and 5-day infusional 5-fluorouracil (5-FU) in a sequential schedule based on our previous combination phase I...
4.
Ohtsu A, Shimada Y, Shirao K, Boku N, Hyodo I, Saito H, et al.
J Clin Oncol
. 2002 Dec;
21(1):54-9.
PMID: 12506170
Purpose: To compare fluorouracil (FU) alone with FU plus cisplatin (FP) and with uracil and tegafur plus mitomycin (UFTM) for patients with advanced gastric cancer in a prospective, randomized, controlled...